Resveratrol improves high-fat diet induced fatty liver and insulin resistance by concomitantly inhibiting proteolytic cleavage of sterol regulatory element-binding proteins, free fatty acid oxidation, and intestinal triglyceride absorption

Neuroprotective effect of resveratrol against brain ischemia reperfusion injury in rats entails reduction of DJ-1 protein expression and activation of PI3K/Akt/GSK3b survival pathway

(2016) Ghada A. Abdel-Aleem et al.   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY

Resveratrol ameliorates fibrosis and inflammation in a mouse model of nonalcoholic steatohepatitis

(2016) Takaomi Kessoku et al.   Scientific Reports

Xanthohumol Improves Diet-induced Obesity and Fatty Liver by Suppressing Sterol Regulatory Element-binding Protein (SREBP) Activation

(2015) Shingo Miyata et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Resveratrol Reverses Cadmium Chloride-induced Testicular Damage and Subfertility by Downregulating p53 and Bax and Upregulating Gonadotropins and Bcl-2 gene Expression

(2014) Samy M ELEAWA et al.   JOURNAL OF REPRODUCTION AND DEVELOPMENT

Effects of resveratrol and other polyphenols in hepatic steatosis

(2014) Leixuri Aguirre   WORLD JOURNAL OF GASTROENTEROLOGY

Resveratrol Suppresses T0901317-Induced Hepatic Fat Accumulation in Mice

(2013) Mingming Gao et al.   AAPS Journal

Differential effects of low-dose resveratrol on adiposity and hepatic steatosis in diet-induced obese mice

(2012) Su-Jung Cho et al.   BRITISH JOURNAL OF NUTRITION

The Scap/SREBP Pathway Is Essential for Developing Diabetic Fatty Liver and Carbohydrate-Induced Hypertriglyceridemia in Animals

(2012) Young-Ah Moon et al.   Cell Metabolism

Homeostasis model assessment of insulin resistance for evaluating insulin sensitivity in patients with type 2 diabetes on insulin therapy

(2012) Kohei Okita et al.   ENDOCRINE JOURNAL

Inhibitory Activities ofCudrania tricuspidataLeaves on Pancreatic LipaseIn Vitroand LipolysisIn Vivo

(2012) Young Sook Kim et al.   Evidence-based Complementary and Alternative Medicine

Alleviative effects of resveratrol on nonalcoholic fatty liver disease are associated with up regulation of hepatic low density lipoprotein receptor and scavenger receptor class B type I gene expressions in rats

(2012) Peng Xin et al.   FOOD AND CHEMICAL TOXICOLOGY

Resveratrol attenuates oxidative stress and prevents steatosis and hypertension in obese rats programmed by early weaning

(2012) Juliana G. Franco et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Resveratrol ameliorates diabetes-related metabolic changes via activation of AMP-activated protein kinase and its downstream targets indb/dbmice

(2012) Gyeong-Min Do et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Resveratrol preconditioning modulates inflammatory response in the rat hippocampus following global cerebral ischemia

(2012) Fabrício Simão et al.   NEUROCHEMISTRY INTERNATIONAL

Hepatic lipid metabolic pathways modified by resveratrol in rats fed an obesogenic diet

(2012) Goiuri Alberdi et al.   NUTRITION

Resveratrol up-regulates hepatic uncoupling protein 2 and prevents development of nonalcoholic fatty liver disease in rats fed a high-fat diet

(2012) Morten Møller Poulsen et al.   NUTRITION RESEARCH

Insulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinase

(2012) J. L. Owen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Anti-diabetic effects of resveratrol

(2011) Tomasz Szkudelski et al.   Annals of the New York Academy of Sciences

Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice

(2011) Soyoung Kim et al.   BIOCHEMICAL PHARMACOLOGY

Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress

(2011) S. Gómez-Zorita et al.   BRITISH JOURNAL OF NUTRITION

AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice

(2011) Yu Li et al.   Cell Metabolism

Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis

(2011) Srinivasan Dasarathy et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Liver mitochondrial function and redox status in an experimental model of non-alcoholic fatty liver disease induced by monosodium l-glutamate in rats

(2011) Murilo de Oliveira Lazarin et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Greater dietary fat oxidation in obese compared with lean men: an adaptive mechanism to prevent liver fat accumulation?

(2010) Leanne Hodson et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Resveratrol Inhibits Neuronal Apoptosis and Elevated Ca2+/Calmodulin-Dependent Protein Kinase II Activity in Diabetic Mouse Retina

(2010) Y.-H. Kim et al.   DIABETES

Fatty Acid Metabolism in the Liver, Measured by Positron Emission Tomography, Is Increased in Obese Individuals

(2010) Patricia Iozzo et al.   GASTROENTEROLOGY

Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model

(2010) R. Scott Rector et al.   JOURNAL OF HEPATOLOGY

Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1–FOXO1 signaling pathway

(2009) Guang-Li Wang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Epidemiology and Natural History of Non-Alcoholic Steatohepatitis

(2009) Curtis K. Argo et al.   Clinics in Liver Disease

Insulin Enhances the Biogenesis of Nuclear Sterol Regulatory Element-binding Protein (SREBP)-1c by Posttranscriptional Down-regulation of Insig-2A and Its Dissociation from SREBP Cleavage-activating Protein (SCAP)·SREBP-1c Complex

(2009) Chandrahasa R. Yellaturu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Non-alcoholic fatty liver disease: Confronting the global epidemic requires better awareness

(2009) H Janaka de Silva et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Dietary resveratrol administration increases MnSOD expression and activity in mouse brain

(2008) Ellen L. Robb et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats

(2008) Leonor Rivera et al.   BIOCHEMICAL PHARMACOLOGY

Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury

(2008) G Serviddio et al.   GUT

Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice

(2008) Catherine Postic et al.   JOURNAL OF CLINICAL INVESTIGATION

Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet

(2008) Jiyun Ahn et al.   JOURNAL OF HEPATOLOGY

Female Rats Fed a High-Fat Diet Were Associated with Vascular Dysfunction and Cardiac Fibrosis in the Absence of Overt Obesity and Hyperlipidemia: Therapeutic Potential of Resveratrol

(2008) M.-C. Aubin et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS